GT Biopharma, Inc. - FORM 10-K - EX-21.1 - OXIS SUBSIDIARIES - March 30, 2010

Attached files

file	filename
10-K - OXIS ANNUAL REPORT 2009 - GT Biopharma, Inc.	oxis10k2009.htm
EX-31.2 - SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER - GT Biopharma, Inc.	ex312.htm
EX-32.1 - SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - GT Biopharma, Inc.	ex321.htm
EX-31.1 - SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - GT Biopharma, Inc.	ex311.htm
EX-32.2 - SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER - GT Biopharma, Inc.	ex322.htm
EX-10.20 - EMPLOYMENT AGREEMENT BY AND BETWEEN OXIS AND BERNARD LANDES, DATED MARCH 11, 2010 - GT Biopharma, Inc.	ex1020.htm
EX-10.19 - ADVISORY AGREEMENT, BETWEEN OXIS INTERNATIONAL, INC. AND GARY M. POST - GT Biopharma, Inc.	ex1019.htm
EX-10.17 - EMPLOYMENT AGREEMENT BY AND BETWEEN OXIS AND MICHAEL HANDELMAN, DATED MARCH 11, 2010 - GT Biopharma, Inc.	ex1017.htm
EX-10.14 - ESCROW AGREEMENT BY AND AMONG OXIS, THEOREM GROUP, LLC, THEOREM CAPITAL, LLC AND LAW OFFICES OF JACQUES CHEN - GT Biopharma, Inc.	ex1014.htm
EX-10.18 - EMPLOYMENT AGREEMENT, DATED MARCH 26, 2010, BETWEEN OXIS INTERNATIONAL, INC. AND ANTHONY J. CATALDO - GT Biopharma, Inc.	ex1018.htm

Exhibit 21.1

SUBSIDIARIES OF OXIS INTERNATIONAL, INC.

As of December 31, 2009, the Company’s subsidiaries were as follows:

Name	Jurisdiction of incorporation

OXIS Therapeutics, Inc.	Delaware
OXIS Isle of Man Limited	Isle of Man